Europe Fusion Biopsy Market Size

Europe Fusion Biopsy Market Size, Trends & Forecast 2026

Europe Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : September-2020 | Number of Pages : 60 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Fusion Biopsy Market

Market Report Description

The Europe Fusion Biopsy Market would witness market growth of 11.1% CAGR during the forecast period (2020-2026). Diagnostics centers are anticipated to grow at a substantial rate in the coming years. It reduces wait times, developing reimbursement paradigm, and cost efficiency are some of the factors that are likely to drive the growth of the fusion biopsy market. The targeted MR/Ultrasound biopsy system is an evolving technology, the higher cost is the main barrier for their implementation in diagnostic centers. Though, it is perceived that when two diagnostic centers become partners and purchase and MR/Ultrasound fusion biopsy system, intending its quick ROI and also increasing demand for fusion biopsy.

Transperineal fusion biopsy is an evolving trend and is anticipated to show the fastest growth in the foreseeable period of time. It has a lower risk of infection and minimal rectal bleeding as compared to the traditional approach is likely to have a positive driver towards the segment growth. Furthermore, the transperineal approach is effective and more efficient in assessing the ventral areas of the prostate that are usually not identified with transrectal fusion biopsy. The market players like and Biopsee and Koelis offers accessories of both transrectal and transperineal fusion biopsy system and they are giving urologist more flexibility to facilitate personalized patient care.

Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: Fusion Biopsy Market in Europe is expected to register a CAGR of 11.1% during the forecast period (2020-2026)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.

Scope of the Europe Fusion Biopsy Market Analysis

Market Segmentation:

By End Use

  • Diagnostic centers
  • Hospitals
  • Ambulatory care centers

By Route

  • Transperineal
  • Transrectal

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Baxter International, Inc. (MedCom)
  • Esaote SpA
  • Eigen
  • KOELIS, Inc.
  • Focal Healthcare, Inc.
  • UC-Care Medical Systems Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Fusion Biopsy Market Related Reports:

Global Market

North America Market

Asia Pacific Market

LAMEA Market

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities